Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (1051-1060 of 1,158) with videos related to

Pageof 116
Sort By:
Lancet (London, England)|May 7, 2019
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trialsRaffaele Piccolo, Kaare H Bonaa, Orestis Efthimiou, et al.
Journal of the American Heart Association|October 8, 2021
Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery RevascularizationRaffaele Piccolo, Kaare H Bonaa, Orestis Efthimiou, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|November 6, 2020
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed TomographyOle De Backer, Uri Landes, Andreas Fuchs, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
JACC. Cardiovascular Interventions|October 29, 2025
Artificial Intelligence in Valvular Heart Disease: Innovations and Future DirectionsAnnette Maznyczka, Rutger-Jan Nuis, Isaac Shiri, et al.
Pageof 116

Showing results (1051-1060 of 1,158) with videos related to

Sort By:
Pageof 116
Lancet (London, England)|May 7, 2019
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trialsRaffaele Piccolo, Kaare H Bonaa, Orestis Efthimiou, et al.
Journal of the American Heart Association|October 8, 2021
Drug-Eluting or Bare-Metal Stents for Left Anterior Descending or Left Main Coronary Artery RevascularizationRaffaele Piccolo, Kaare H Bonaa, Orestis Efthimiou, et al.
Lancet (London, England)|September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisChristoph Stettler, Simon Wandel, Sabin Allemann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 13, 2019
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trialKuniaki Takahashi, Norihiro Kogame, Mariusz Tomaniak, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|November 6, 2020
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed TomographyOle De Backer, Uri Landes, Andreas Fuchs, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
JACC. Cardiovascular Interventions|October 29, 2025
Artificial Intelligence in Valvular Heart Disease: Innovations and Future DirectionsAnnette Maznyczka, Rutger-Jan Nuis, Isaac Shiri, et al.
Pageof 116